• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • Contact Us
  • Careers

Careers

Careers

Working at Celyad Oncology

Developing innovative cell therapies against cancer

Celyad Oncology unites people who are constantly pushing back the limits of science, technology, and medicine to deliver therapies to cancer patients with unmet medical needs.

053_981be

Eliminate Cancer. Improve Life.

Our teams are collaborating towards ambitious and innovative cell therapy programs and fundamental scientific and clinical developments

No current opportunities

WHY DID THEY JOIN CELYAD ONCOLOGY?

“I have always been impressed by Celyad's cutting edge technology and ambition

to find novel therapies for people with cancer. I followed the Company for many years before joining, and even more so from the moment the Company was listed on Euronext in 2013 and then on Nasdaq in 2015. This double listing was unique in Wallonia and I always thought that working in such a dynamic financial environment would be very exciting. We, the Finance Team, are responsible for managing all the financial operations of the business, and also for providing complete regulated financial information to our shareholders and new potential investors.”

David Georges – Senior Director, Finance
Joined Celyad Oncology in 2019

WHY DID THEY JOIN CELYAD ONCOLOGY?

“Since childhood, I have been fascinated by the immune system

and methods aimed at reinforcing to better fight diseases. I am very glad to work at Celyad Oncology and be part of the journey towards providing cancer therapies based on immune cells that could have a real impact on patient’s lives. The R&D team is working actively to develop innovative technologies or new platforms to push the cellular immunotherapy field a little further. In this aspect we differentiate from others in the field, by developing new targets and non-gene editing technologies to eventually propose in the near future new treatment options that would benefit a larger patient population. ”

Caroline Lonez – Senior Manager, R&D business development and communication
Joined Celyad Oncology in 2016

Previous Next Pause Play

180_981be

Send us a message

We're always on the lookout for top talent.  Send us your application by e-mail at job@celyad.com and we will get back to you when something opens up.

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use